Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sacchi

Showing results (131-140 of 182) with videos related to

Pageof 19
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|May 1, 1995
Research on heterocyclic compounds. XXXIII--Synthesis and analgesic activity of imidazo[1,2-b]pyridazine-2-acetic acid derivativesE Luraschi, F Arena, A Sacchi, et al.
Experimental Cell Research|January 1, 1994
Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypesR Falcioni, L Cimino, M P Gentileschi, et al.
Oncogene|September 22, 1999
E2F activates late-G1 events but cannot replace E1A in inducing S phase in terminally differentiated skeletal muscle cellsD Pajalunga, D Tognozzi, M Tiainen, et al.
EMBO Reports|October 19, 2001
The cyclin B1 gene is actively transcribed during mitosis in HeLa cellsS Sciortino, A Gurtner, I Manni, et al.
Endocrinology|November 1, 1995
Molecular basis of estrogen regulation of Hageman factor XII gene expressionA Farsetti, S Misiti, F Citarella, et al.
Experimental Cell Research|November 5, 1997
Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell linesR Falcioni, A Antonini, P Nisticò, et al.
Chirurgia Italiana|October 1, 1980
[Utility of angiography in the diagnosis and localization of hepatic carcinomas]A Paci, G Puricelli, C Martinenghi, et al.
International Journal of Immunopathology and Pharmacology|April 19, 2011
Zoledronic acid enhances Vδ2 T-lymphocyte antitumor response to human glioma cell linesE Cimini, P Piacentini, A Sacchi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Retinoic acid and cAMP differentially regulate human chromogranin A promoter activity during differentiation of neuroblastoma cellsC Gaetano, I Manni, G Bossi, et al.
Gene Therapy|August 24, 1999
Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration scheduleA Biroccio, D D Bufalo, A Ricca, et al.
Pageof 19

Showing results (131-140 of 182) with videos related to

Sort By:
Pageof 19
Farmaco (Societa Chimica Italiana : 1989)|May 1, 1995
Research on heterocyclic compounds. XXXIII--Synthesis and analgesic activity of imidazo[1,2-b]pyridazine-2-acetic acid derivativesE Luraschi, F Arena, A Sacchi, et al.
Experimental Cell Research|January 1, 1994
Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypesR Falcioni, L Cimino, M P Gentileschi, et al.
Oncogene|September 22, 1999
E2F activates late-G1 events but cannot replace E1A in inducing S phase in terminally differentiated skeletal muscle cellsD Pajalunga, D Tognozzi, M Tiainen, et al.
EMBO Reports|October 19, 2001
The cyclin B1 gene is actively transcribed during mitosis in HeLa cellsS Sciortino, A Gurtner, I Manni, et al.
Endocrinology|November 1, 1995
Molecular basis of estrogen regulation of Hageman factor XII gene expressionA Farsetti, S Misiti, F Citarella, et al.
Experimental Cell Research|November 5, 1997
Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell linesR Falcioni, A Antonini, P Nisticò, et al.
Chirurgia Italiana|October 1, 1980
[Utility of angiography in the diagnosis and localization of hepatic carcinomas]A Paci, G Puricelli, C Martinenghi, et al.
International Journal of Immunopathology and Pharmacology|April 19, 2011
Zoledronic acid enhances Vδ2 T-lymphocyte antitumor response to human glioma cell linesE Cimini, P Piacentini, A Sacchi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Retinoic acid and cAMP differentially regulate human chromogranin A promoter activity during differentiation of neuroblastoma cellsC Gaetano, I Manni, G Bossi, et al.
Gene Therapy|August 24, 1999
Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration scheduleA Biroccio, D D Bufalo, A Ricca, et al.
Pageof 19